Endometrial Cancers
Adjuvant durvalumab does not extend DFS in early-stage lung cancer
Adjuvant durvalumab failed to improve outcomes compared with placebo for certain patients with early-stage lung cancer, according to the agent’s manufacturer.
Durvalumab regimen improves survival in muscle-invasive bladder cancer
The combination of durvalumab and chemotherapy improved outcomes compared with neoadjuvant chemotherapy alone for patients with muscle-invasive bladder cancer, according to the agent’s manufacturer.
Endometriosis increases risks for ovarian, endometrial cancers
Endometriosis was significantly associated with higher risks for both ovarian and endometrial cancers, but was not significantly associated with cervical cancer risk, according to an analysis published in Current Oncology.
Black women less likely to receive lifesaving hysterectomies for endometrial cancer
Compared with white women, Black women with a low-risk form of endometrial cancer less frequently received a hysterectomy and had lower survival rates, according to research conducted at Cedars-Sinai Cancer Center.